BIOLOGIC THERAPY RETENTION IN RHEUMATOID ARTHRITIS (RA) PATIENTS (PTS) ACCORDING TO THE MOSCOW ARTHRITIS REGISTRY (MAR)

被引:0
|
作者
Lukina, G. [1 ]
Koltsova, E. [2 ]
Schmidt, E. [3 ]
Zhilyaev, E. [4 ]
机构
[1] VA Nasonova Res Inst Rheumatol, Moscow Clin Sci Ctr, Moscow, Russia
[2] Res Inst Org Hlth & Healthcare Management, Moscow, Russia
[3] City Clin Hosp 1, Moscow, Russia
[4] Russian Med Acad Continuing Profess Educ, CJSC European Med Ctr, Moscow, Russia
关键词
D O I
10.1136/annrheumdis-2017-eular.3657
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SAT0200
引用
收藏
页码:848 / 848
页数:1
相关论文
共 50 条
  • [21] Safety of biologic therapy in rheumatoid arthritis
    Woodrick, Robert S.
    Ruderman, Eric M.
    NATURE REVIEWS RHEUMATOLOGY, 2011, 7 (11) : 639 - 652
  • [22] Safety of biologic therapy in rheumatoid arthritis
    Robert S. Woodrick
    Eric M. Ruderman
    Nature Reviews Rheumatology, 2011, 7 : 639 - 652
  • [23] Malignancy and biologic therapy in rheumatoid arthritis
    Askling, Johan
    Bongartz, Tim
    CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (03) : 334 - 339
  • [24] BIOLOGIC DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS ON A SPANISH REGISTRY: PREDICTORS OF THERAPY DISCONTINUATION DUE TO REMISSION
    Hernandez, M. V.
    Gomez-Puerta, J. A.
    Canete, J. D.
    Gomez-Reino, J. J.
    Sanmarti, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 464 - 465
  • [25] Rheumatoid arthritis and the era of biologic therapy
    Anshuman P. Malaviya
    Andrew J. K. Östör
    Inflammopharmacology, 2012, 20 (2) : 59 - 69
  • [26] Preferences for treatment with biologic agents in rheumatoid arthritis (RA).
    Constantinescu, Florina
    Wani, Shoba
    Gaucher, Susan
    Weinstein, Arthur
    Fraenkel, Liana
    ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 4096 - 4096
  • [27] Risks of Herpes Zoster in Patients With Rheumatoid Arthritis According to Biologic Disease-Modifying Therapy
    Yun, Huifeng
    Xie, Fenglong
    Delzell, Elizabeth
    Chen, Lang
    Levitan, Emily B.
    Lewis, James D.
    Saag, Kenneth G.
    Beukelman, Timothy
    Winthrop, Kevin
    Baddley, John W.
    Curtis, Jeffrey R.
    ARTHRITIS CARE & RESEARCH, 2015, 67 (05) : 731 - 736
  • [28] COMPARISON OF CLINICAL CHARACTERISTICS OF PATIENTS WITH RHEUMATOID ARTHRITIS (RA) RECEIVING A BIOLOGIC MONOTHERAPY AND BIOLOGIC COMBINATION THERAPY IN THE UNITED STATES
    Narayanan, S.
    Lu, Y.
    Hutchings, R.
    Baynton, E.
    VALUE IN HEALTH, 2014, 17 (03) : A55 - A55
  • [29] ROMANIAN REGISTRY OF RHEUMATIC DISEASES: EFFICACY AND SAFETY OF BIOLOGIC THERAPY IN RHEUMATOID ARTHRITIS
    Codreanu, C.
    Mogosan, C.
    Enache, L.
    Stanciu, D.
    Ionescu, R.
    Opris, D.
    Rednic, S.
    Parvu, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 458 - 458
  • [30] LONG-TERM SAFETY OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS (RA) PATIENTS (PTS)
    van Vollenhoven, Ronald
    Scali, Juan
    Curtis, Jeffrey R.
    Krasnow, Joel
    Vernon, Emma
    Alten, Rieke
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1087 - 1087